Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYCell death & disease

Identification and validation of NCOA5-ZCCHC3/FGF22 axis as a prognostic marker in lung adenocarcinoma migration and invasion.

  • Yiran Yu1
  • Wen Jin2
  • Erdun Chaogetu3
  • Xiaoli Zhang4
  • Xi Liu4
  • Yahan Gao2
  • Feng Li2
  • Rila Su5,6
6 affiliations
  1. 1Graduate School of Inner Mongolia Medical University, Hohhot, China.
  2. 2Clinical Medical Research Center of Inner Mongolia People's Hospital, Hohhot, China.
  3. 3Thoracic Surgery Department of Inner Mongolia People's Hospital, Hohhot, China.
  4. 4Oncology Department of Inner Mongolia People's Hospital, Hohhot, China.
  5. 5Clinical Medical Research Center of Inner Mongolia People's Hospital, Hohhot, China. [email protected].
  6. 6Oncology Department of Inner Mongolia People's Hospital, Hohhot, China. [email protected].
Read full textPDFDOICite

Abstract

Lung adenocarcinoma (LUAD), the most common subtype of lung cancer, is associated with substantial global mortality. Nuclear receptor coactivator 5 (NCOA5) has been implicated in several malignancies; however, its functional role and regulatory mechanisms in LUAD remain largely unknown. In this study, NCOA5 expression was evaluated in 94 paired LUAD and adjacent tissues using immunohistochemistry, RT-PCR, and Western blotting. Functional analyses were conducted using shRNA knockdown, CRISPR-mediated knockout, and overexpression models to assess the effects of NCOA5 on LUAD cell proliferation, migration, invasion, apoptosis, cell cycle progression, and organoid formation. Xenograft models were used to validate tumorigenicity in vivo. IP-MS and co-immunoprecipitation identified NCOA5-interacting proteins, while ChIP-seq and dual-luciferase assays interrogated downstream transcriptional regulation. NCOA5 was significantly upregulated in LUAD tissues and associated with advanced stage, poor differentiation, and reduced overall survival, serving as an independent prognostic factor (P < .040). NCOA5 knockdown inhibited LUAD cell proliferation, migration, invasion, induced G0/G1 arrest, promoted apoptosis, reduced organoid formation, and suppressed xenograft growth, whereas NCOA5 overexpression produced the opposite effects. Among 39 candidate interacting proteins identified by IP-MS, ZCCHC3 was validated as a direct NCOA5-binding partner. ZCCHC3 depletion phenocopied NCOA5 loss and reversed NCOA5-induced proliferation, migration, invasion, and colony formation, supporting a functional NCOA5-ZCCHC3 interaction. ChIP-seq analysis identified fibroblast growth factor 22 (FGF22) as a direct transcriptional target of NCOA5. FGF22 was markedly downregulated in LUAD tissues and higher FGF22 expression was associated with improved patient survival. NCOA5 suppressed FGF22 transcription, while NCOA5 inhibition increased FGF22 expression. Functionally, FGF22 knockdown enhanced LUAD aggressiveness, whereas FGF22 restoration abrogated the oncogenic effects of NCOA5 in vitro and in vivo. Collectively, these findings identify a previously unrecognized NCOA5-ZCCHC3/FGF22 axis that drives LUAD progression and provide new mechanistic insight into the role of NCOA5 in LUAD biology.

Related

  1. Construction of a prognostic model and immune landscape analysis for lung adenocarcinoma utilizing a bioinformatics signature derived from acrolein-related genes, and identification of associated subtypes.
    Jian Chen, Yin Fu, Jiangwei Hu +1
    Journal of cardiothoracic surgeryPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMCDOAJ
  2. Quantifying Localized Tumor-Infiltrating Lymphocytes by Deep Learning on H&E Images: Analytical Validation and Prognostic Value in Lung Adenocarcinoma
    B. L. Osinski, K. Ingale, A. Huang +7
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  3. Development and Validation of an Automated Image-Based Method for Prognostic Stratification in Lung Adenocarcinoma using Immunohistochemical Markers
    F. Carraro, M. Sanguesa, A. Irisarri +7
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  4. Cross-Platform External Validation of a Locked 12-Gene Prognostic Panel in Lung Adenocarcinoma Benchmarked Against Pathological Stage.
    Faris Alrumaihi
    GenesPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Identification and validation of prognostic characteristics of survival risk marker genes associated with ferroptosis and iron metabolism in breast cancer
    Mengxi Li, Baoqing Zhao, Zhenwang Zhang
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicasPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{yu2026identification,
  title = {{Identification and validation of NCOA5-ZCCHC3/FGF22 axis as a prognostic marker in lung adenocarcinoma migration and invasion.}},
  author = {Yiran Yu and Wen Jin and Erdun Chaogetu and Xiaoli Zhang and Xi Liu and Yahan Gao and Feng Li and Rila Su},
  journal = {Cell death \& disease},
  year = {2026},
  month = jul,
  doi = {10.1038/s41419-026-09127-9},
  url = {https://europepmc.org/article/MED/42901917},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Identification and validation of NCOA5-ZCCHC3/FGF22 axis as a prognostic marker in lung adenocarcinoma migration and invasion.
AU  - Yiran Yu
AU  - Wen Jin
AU  - Erdun Chaogetu
AU  - Xiaoli Zhang
AU  - Xi Liu
AU  - Yahan Gao
AU  - Feng Li
AU  - Rila Su
PY  - 2026
DA  - 2026/07/01
JO  - Cell death & disease
DO  - 10.1038/s41419-026-09127-9
UR  - https://europepmc.org/article/MED/42901917
AB  - Lung adenocarcinoma (LUAD), the most common subtype of lung cancer, is associated with substantial global mortality. Nuclear receptor coactivator 5 (NCOA5) has been implicated in several malignancies; however, its functional role and regulatory mechanisms in LUAD remain largely unknown. In this study, NCOA5 expression was evaluated in 94 paired LUAD and adjacent tissues using immunohistochemistry, RT-PCR, and Western blotting. Functional analyses were conducted using shRNA knockdown, CRISPR-mediated knockout, and overexpression models to assess the effects of NCOA5 on LUAD cell proliferation, migration, invasion, apoptosis, cell cycle progression, and organoid formation. Xenograft models were used to validate tumorigenicity in vivo. IP-MS and co-immunoprecipitation identified NCOA5-interacting proteins, while ChIP-seq and dual-luciferase assays interrogated downstream transcriptional regulation. NCOA5 was significantly upregulated in LUAD tissues and associated with advanced stage, poor differentiation, and reduced overall survival, serving as an independent prognostic factor (P < .040). NCOA5 knockdown inhibited LUAD cell proliferation, migration, invasion, induced G0/G1 arrest, promoted apoptosis, reduced organoid formation, and suppressed xenograft growth, whereas NCOA5 overexpression produced the opposite effects. Among 39 candidate interacting proteins identified by IP-MS, ZCCHC3 was validated as a direct NCOA5-binding partner. ZCCHC3 depletion phenocopied NCOA5 loss and reversed NCOA5-induced proliferation, migration, invasion, and colony formation, supporting a functional NCOA5-ZCCHC3 interaction. ChIP-seq analysis identified fibroblast growth factor 22 (FGF22) as a direct transcriptional target of NCOA5. FGF22 was markedly downregulated in LUAD tissues and higher FGF22 expression was associated with improved patient survival. NCOA5 suppressed FGF22 transcription, while NCOA5 inhibition increased FGF22 expression. Functionally, FGF22 knockdown enhanced LUAD aggressiveness, whereas FGF22 restoration abrogated the oncogenic effects of NCOA5 in vitro and in vivo. Collectively, these findings identify a previously unrecognized NCOA5-ZCCHC3/FGF22 axis that drives LUAD progression and provide new mechanistic insight into the role of NCOA5 in LUAD biology.
SN  - 2041-4889
ER  -